Authors: Jianu, Constantin S.¹; Fossmark, Reidar¹; Syversen, Unni²; Hauso, ØØyvind¹; Fykse, Vidar¹; Waldum, Helge L.¹

Source: Scandinavian Journal of Gastroenterology, Volume 46, Number 4, April 2011 , pp. 456-463(8)

Publisher: Informa Healthcare

Abstract:

<title>Abstract</title>

Background. Gastric carcinoids type 1 (GC1) are neuroendocrine tumors (NETs) arising from the enterochromaffin-like (ECL) cells in patients with chronic atrophic gastritis (CAG). The treatment of GC1 has been endoscopic polypectomy or surgical tumor excision and antrectomy. One year treatment with somatostatin analogs (SSAs) diminished tumor load and ECL cell density. The effect persisted 1 year after treatment was discontinued. However, the optimal SSA dose and treatment duration are unknown. Objectives. The aim of the present work was to study macroscopic and histopathological changes in the stomach and serum markers gastrin and chromogranin A (CgA) in GC1 patients 5 years after 1 year of octreotide long-acting release (LAR) treatment. Material and methods. Five patients with GC1 were included 5 years after the initial year of octreotide LAR treatment. All patients underwent upper gastrointestinal endoscopy including tumor and mucosal biopsies from oxyntic mucosa, chest and abdominal computer tomography and octreotide scintigraphy. Fasting serum gastrin and CgA were also measured. Results. At 5 years, one patient had a highly malignant gastric tumor, one patient had an increased number of GCs, regional and distant metastases and three patients had an increased number of GCs. Serum gastrin and CgA increased to pre-treatment levels after 1 year of follow-up and were unchanged at the 5-year follow-up. Conclusions. The disease had progressed in all five GCs patients treated with octreotide for 12 months at 5 years of follow-up. This suggests that, if started, octreotide treatment should not be discontinued in these patients.

Keywords: Atrophic gastritis; chromogranin A; gastric carcinoids; gastrin; hypergastrinemia; somatostatin analogs

Document Type: Research article

DOI: http://dx.doi.org/10.3109/00365521.2010.539255

Affiliations: 1: 1Department of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway 2: 2Department of Endocrinology, St. Olavs Hospital, Trondheim, Norway

Publication date: 2011-04-01

More about this publication?

• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Gastroenterology
• By this author: Jianu, Constantin S. ;  Fossmark, Reidar ;  Syversen, Unni ;  Hauso, ØØyvind ;  Fykse, Vidar ;  Waldum, Helge L.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers